What one share of Senestech holds
We have developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Our current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.
Senestech’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.46 |
|---|---|
| Profit | −$1.37 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$1.32 |
| Cash and investments | $0.96 |
| Debt | $0.03 |
| Book value | $1.14 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | $17.81 | −$115.10 | $2.22 | −$115.17 | — | — |
| 2024 | $2.66 | −$8.86 | $0.12 | −$8.76 | — | $2.42 |
| 2025 | $0.68 | −$1.95 | $0.04 | −$1.80 | — | $1.83 |
Common questions about Senestech
How much does one share of Senestech earn?
Over the last 12 months, Senestech lost $1.37 for each share on $0.46 of sales.
Does Senestech pay a dividend?
Senestech didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Senestech’s book value per share?
Senestech’s book value is $1.14 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Senestech have?
Each share of Senestech has $0.96 of cash and investments and $0.03 of debt, as of June 30, 2026.
What is Senestech’s free cash flow per share?
−$1.32 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.